Longevity Peptides
Cross-source consensus on Longevity Peptides from 1 sources and 5 claims.
1 sources · 5 claims
How it works
Background
Highlighted claims
- Aging is increasingly recognized as a modifiable risk factor for all chronic disease, and senolytics represent a direct intervention in that process. — Peptide Therapy: A Clinical Guide to Applications, Evidence, and Implementation
- The medical view that aging is non-modifiable has shifted toward recognizing it as a modifiable risk factor for virtually all chronic disease. — Peptide Therapy: A Clinical Guide to Applications, Evidence, and Implementation
- Epithalon is released from the pineal gland and promotes telomerase production, extending telomere length as a direct mechanism involved in biological aging. — Peptide Therapy: A Clinical Guide to Applications, Evidence, and Implementation
- Foxo4-DRI is a senolytic peptide that selectively clears senescent cells. — Peptide Therapy: A Clinical Guide to Applications, Evidence, and Implementation
- MOTS-C is a mitochondria-derived peptide relevant to cellular health broadly, as mitochondria participate in apoptosis, cell signaling, and nuclear communication beyond ATP production. — Peptide Therapy: A Clinical Guide to Applications, Evidence, and Implementation